رجوع
نطاق اليوم
KWD 116.25
KWD 122.00
نطاق 52 أسبوعًا
KWD 102.97
KWD 175.77
حجم التداول
807,765
متوسط 50 يوم / 200 يوم
KWD 140.91
/
KWD 138.89
الإغلاق السابق
KWD 113.88
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 134.1 | 0.4 |
| P/B | 3.1 | 2.9 |
| ROE % | 2.4 | 3.7 |
| Net Margin % | 6.6 | 3.9 |
| Rev Growth 5Y % | 2.4 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 177.500
+52.6%
Low: KWD 150.000
High: KWD 200.000
مكرر الربحية المستقبلي
58.5
ربحية السهم المستقبلية
KWD 1.988
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
830 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 5.690
KWD 5.542 – KWD 5.787
|
1.5 B | 1 |
| FY2029 |
KWD 4.487
KWD 4.370 – KWD 4.563
|
1.3 B | 1 |
| FY2028 |
KWD 3.304
KWD 2.644 – KWD 3.791
|
1.1 B | 5 |
النقاط الرئيسية
Revenue grew 2.43% annually over 5 years — modest growth
ROE of 2.40% is below average
Debt/Equity of 0.33 — conservative balance sheet
Generating 93.90M in free cash flow
P/E of 134.05 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.93%
النمو
Revenue Growth (5Y)
2.43%
Revenue (1Y)16.36%
Earnings (1Y)N/A
FCF Growth (3Y)11.94%
الجودة
Return on Equity
2.40%
ROIC1.60%
Net Margin6.62%
Op. Margin8.07%
الأمان
Debt / Equity
0.33
Current Ratio8.37
Interest Coverage2.57
التقييم
P/E Ratio
134.05
P/B Ratio3.11
EV/EBITDA112.09
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.36% | Revenue Growth (3Y) | 8.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 17.20% |
| Revenue Growth (5Y) | 2.43% | Earnings Growth (5Y) | -21.43% |
| Profitability | |||
| Revenue (TTM) | 738.26M | Net Income (TTM) | 48.89M |
| ROE | 2.40% | ROA | 1.66% |
| Gross Margin | 47.09% | Operating Margin | 8.07% |
| Net Margin | 6.62% | Free Cash Flow (TTM) | 93.90M |
| ROIC | 1.60% | FCF Growth (3Y) | 11.94% |
| Safety | |||
| Debt / Equity | 0.33 | Current Ratio | 8.37 |
| Interest Coverage | 2.57 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 134.05 | P/B Ratio | 3.11 |
| P/S Ratio | 8.88 | PEG Ratio | -0.65 |
| EV/EBITDA | 112.09 | Dividend Yield | 0.00% |
| Market Cap | 6.55B | Enterprise Value | 6.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 738.26M | 634.44M | 632.36M | 801.54M | 670.53M |
| Net Income | 48.89M | -25.51M | 35.60M | 185.96M | 128.29M |
| EPS (Diluted) | 0.86 | -0.46 | 0.63 | 3.24 | 2.24 |
| Gross Profit | 347.62M | 274.65M | 278.44M | 455.71M | 391.25M |
| Operating Income | 59.58M | -35.11M | 47.70M | 224.67M | 167.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.95B | 2.83B | 2.83B | 2.53B | 2.36B |
| Total Liabilities | 843.57M | 856.95M | 866.34M | 620.90M | 608.29M |
| Shareholders' Equity | 2.11B | 1.97B | 1.96B | 1.91B | 1.75B |
| Total Debt | 689.95M | 686.25M | 711.80M | 422.96M | 366.05M |
| Cash & Equivalents | 566.02M | 757.36M | 751.32M | 523.46M | 603.81M |
| Current Assets | 1.14B | 1.07B | 1.11B | 998.12M | 931.68M |
| Current Liabilities | 135.83M | 126.79M | 164.94M | 404.20M | 375.26M |